The Federal Trade Commission has given the green light to Amgen's purchase of Horizon Therapeutics.

Share:
More In Business
AT&T Shares Drop to 30-Year Low
Shares of AT&T hit a 30-year low after reports showed thousands of lead-covered cables in several locations across the country. The Wall Street Journal reported on the story earlier in July.
Load More